We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXPI icon
2276
NXP Semiconductors
NXPI
$60.4B
$15K ﹤0.01%
125
-86
-41% -$9.93K
OGS icon
2277
ONE Gas
OGS
$5.04B
$15K ﹤0.01%
210
-6,306
-97% -$478K
PROV icon
2278
Provident Financial
PROV
$112M
$15K ﹤0.01%
817
+617
+309% +$11.8K
RLGT icon
2279
Radiant Logistics
RLGT
$395M
$15K ﹤0.01%
3,213
-3,032
-49% -$14.7K
SD icon
2280
SandRidge Energy
SD
$503M
$15K ﹤0.01%
710
-1,807
-72% -$33.7K
SMG icon
2281
ScottsMiracle-Gro
SMG
$3.66B
$15K ﹤0.01%
142
-351
-71% -$35.1K
SRDX
2282
DELISTED
Surmodics
SRDX
$15K ﹤0.01%
530
-3,799
-88% -$116K
TBBK icon
2283
The Bancorp
TBBK
$2.9B
$15K ﹤0.01%
1,540
-8,069
-84% -$74K
TBPH icon
2284
Theravance Biopharma
TBPH
$877M
$15K ﹤0.01%
546
-6,108
-92% -$181K
TEF
2285
DELISTED
Telefonica
TEF
$15K ﹤0.01%
1,980
-5,993
-75% -$49.2K
TQQQ icon
2286
ProShares UltraPro QQQ
TQQQ
$37.9B
$15K ﹤0.01%
2,568
-1,579,440
-100% -$8.64M
TTC icon
2287
Toro Company
TTC
$9.49B
$15K ﹤0.01%
232
-997
-81% -$63.2K
MDRX
2288
DELISTED
Veradigm Inc. Common Stock
MDRX
$15K ﹤0.01%
1,016
-33,030
-97% -$459K
BBBY
2289
DELISTED
Bed Bath & Beyond Inc
BBBY
$15K ﹤0.01%
698
-564
-45% -$12.2K
XELA
2290
DELISTED
Exela Technologies, Inc. Common Stock
XELA
0
EBSB
2291
DELISTED
Meridian Bancorp, Inc.
EBSB
$15K ﹤0.01%
729
-4,088
-85% -$80.8K
EGOV
2292
DELISTED
NIC Inc
EGOV
$15K ﹤0.01%
+900
New +$15.2K
NBL
2293
DELISTED
Noble Energy, Inc.
NBL
$15K ﹤0.01%
500
-267
-35% -$7.31K
WUBA
2294
DELISTED
58.com Inc
WUBA
$15K ﹤0.01%
211
-89
-30% -$6.16K
RARX
2295
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$15K ﹤0.01%
1,713
-2,698
-61% -$33.2K
TRCB
2296
DELISTED
Two River Bancorp
TRCB
$15K ﹤0.01%
838
+306
+58% +$5.75K
MCRN
2297
DELISTED
Milacron Holdings Corp.
MCRN
$15K ﹤0.01%
800
-6,147
-88% -$110K
CRAY
2298
DELISTED
Cray, Inc.
CRAY
$15K ﹤0.01%
623
-4,988
-89% -$106K
ENLK
2299
DELISTED
EnLink Midstream Partners, LP
ENLK
$15K ﹤0.01%
970
-1,511
-61% -$23.7K
ABCD
2300
DELISTED
Cambium Learning Group, Inc.
ABCD
$15K ﹤0.01%
2,666
-181
-6% -$1.08K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.